Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Evolution and Predictive Factors of Improvement of Obstructive Sleep Apnea in an Obese Population After Bariatric Surgery.

Magne F, Gomez E, Marchal O, Malvestio P, Reibel N, Brunaud L, Ziegler O, Quilliot D, Chabot F, Chaouat A.

J Clin Sleep Med. 2019 Oct 15;15(10):1509-1516. doi: 10.5664/jcsm.7988.

PMID:
31596217
2.

Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease.

Savale L, Habibi A, Lionnet F, Maitre B, Cottin V, Jais X, Chaouat A, Artaud-Macari E, Canuet M, Prevot G, Chantalat-Auger C, Montani D, Sitbon O, Galacteros F, Simonneau G, Parent F, Bartolucci P, Humbert M.

Eur Respir J. 2019 Sep 19. pii: 1900585. doi: 10.1183/13993003.00585-2019. [Epub ahead of print]

PMID:
31537700
3.

Evolution and Predictive Factors of Improvement of Obstructive Sleep Apnea in an Obese Population After Bariatric Surgery.

Magne F, Gomez E, Marchal O, Malvestio P, Reibel N, Brunaud L, Ziegler O, Quilliot D, Chabot F, Chaouat A.

J Clin Sleep Med. 2019 Sep 12. pii: jc-19-00119. [Epub ahead of print]

PMID:
31513528
4.

T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease.

Maurac A, Lardenois É, Eyries M, Ghigna MR, Petit I, Montani D, Guillaumot A, Caput B, Chabot F, Chaouat A.

Eur Respir J. 2019 Aug 22;54(2). pii: 1900388. doi: 10.1183/13993003.00388-2019. Print 2019 Aug. No abstract available.

PMID:
31164435
5.

Prevalence and management of chronic breathlessness in COPD in a tertiary care center.

Carette H, Zysman M, Morelot-Panzini C, Perrin J, Gomez E, Guillaumot A, Burgel PR, Deslee G, Surpas P, Le Rouzic O, Perez T, Chaouat A, Roche N, Chabot F; Initiatives BPCO (bronchopneumopathie chronique obstructive) Scientific Committee and Investigators.

BMC Pulm Med. 2019 May 16;19(1):95. doi: 10.1186/s12890-019-0851-5.

6.

[A case of bronchiectasis due to light chain deposition disease].

Millet F, Gomez E, Hirschi S, Petit I, Chenard MP, Mouget B, Guillaumot A, Chaouat A, Colombat M, Chabot F.

Rev Mal Respir. 2019 Apr;36(4):538-542. doi: 10.1016/j.rmr.2018.11.008. Epub 2019 Jan 24. French.

PMID:
30686554
7.

Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases.

Eyries M, Montani D, Nadaud S, Girerd B, Levy M, Bourdin A, Trésorier R, Chaouat A, Cottin V, Sanfiorenzo C, Prevot G, Reynaud-Gaubert M, Dromer C, Houeijeh A, Nguyen K, Coulet F, Bonnet D, Humbert M, Soubrier F.

Eur Respir J. 2019 Mar 14;53(3). pii: 1801371. doi: 10.1183/13993003.01371-2018. Print 2019 Mar.

PMID:
30578383
8.

[Drug-induced interstitial pneumonitis due to avelumab: A case report].

Brie V, Faure M, Garon J, Petit I, Gomez E, Knoepfli A, Decavele M, Petitpain N, Chabot F, Chaouat A.

Rev Mal Respir. 2018 Nov;35(9):978-982. doi: 10.1016/j.rmr.2018.07.005. Epub 2018 Oct 11. French.

PMID:
30318432
9.

Images in vascular medicine. Unexpected cause of recurrent haemoptysis.

Beringuer H, Vaillant P, Chaouat A, Tiotiu A.

Vasc Med. 2019 Feb;24(1):91-92. doi: 10.1177/1358863X18801519. Epub 2018 Sep 24. No abstract available.

PMID:
30246609
10.

Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension.

Weatherald J, Boucly A, Launay D, Cottin V, Prévot G, Bourlier D, Dauphin C, Chaouat A, Savale L, Jaïs X, Jevnikar M, Traclet J, De Groote P, Simonneau G, Hachulla E, Mouthon L, Montani D, Humbert M, Sitbon O.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800678. doi: 10.1183/13993003.00678-2018. Print 2018 Oct.

PMID:
30209196
11.

Three-Dimensional Echocardiography for the Assessment of Right Ventriculo-Arterial Coupling.

Aubert R, Venner C, Huttin O, Haine D, Filippetti L, Guillaumot A, Mandry D, Marie PY, Juilliere Y, Chabot F, Chaouat A, Selton-Suty C.

J Am Soc Echocardiogr. 2018 Aug;31(8):905-915. doi: 10.1016/j.echo.2018.04.013. Epub 2018 Jun 27.

PMID:
29958760
12.

Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.

Ribeiro Baptista B, Petitpain N, Gomez E, Yelehé-Okouma M, Valentin S, Guillaumot A, Chabot F, Chaouat A.

Fundam Clin Pharmacol. 2019 Feb;33(1):127-129. doi: 10.1111/fcp.12396. Epub 2018 Jul 15.

PMID:
29956855
13.

[Evaluation of cardiac MRI in the follow up assessment of patients with pulmonary arterial hypertension].

Chaouat A, Cherifi A, Sitbon O, Girerd N, Zysman M, Faure M, Mandry D, Mercy M, Guillaumot A, Fay R, Marie PY, Chabot F.

Rev Mal Respir. 2018 Sep;35(7):749-758. doi: 10.1016/j.rmr.2018.01.010. Epub 2018 Jun 23. French.

PMID:
29945811
14.

[Tunnelled central venous catheter infection during treatment with epoprostenol].

Koszutski M, Faure M, Guillaumot A, Gomez E, Mercy M, Chabot F, Chaouat A.

Rev Mal Respir. 2018 Mar;35(3):324-327. doi: 10.1016/j.rmr.2017.03.037. Epub 2018 Mar 28. French.

PMID:
29602480
15.

An official European Respiratory Society statement: pulmonary haemodynamics during exercise.

Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, Garcia G, Grünig E, Howard L, Humbert M, Lau E, Laveneziana P, Lewis GD, Naeije R, Peacock A, Rosenkranz S, Saggar R, Ulrich S, Vizza D, Vonk Noordegraaf A, Olschewski H.

Eur Respir J. 2017 Nov 22;50(5). pii: 1700578. doi: 10.1183/13993003.00578-2017. Print 2017 Nov. Erratum in: Eur Respir J. 2018 Jan 18;51(1):.

16.

Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability.

Revuz S, Decullier E, Ginon I, Lamblin N, Hatron PY, Kaminsky P, Carette MF, Lacombe P, Simon AC, Rivière S, Harlé JR, Fraisse A, Lavigne C, Leguy-Seguin V, Chaouat A, Khouatra C, Dupuis-Girod S, Hachulla E.

PLoS One. 2017 Oct 5;12(10):e0184227. doi: 10.1371/journal.pone.0184227. eCollection 2017.

17.

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, Chaouat A, Chabanne C, Bourdin A, Parent F, Montani D, Simonneau G, Humbert M, Sitbon O.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700889. doi: 10.1183/13993003.00889-2017. Print 2017 Aug.

18.

Can MRI detect pulmonary hypertension in a population pre-selected by echocardiography?

Venner C, Odille F, Voilliot D, Chaouat A, Chabot F, Felblinger J, Bonnemains L.

Acta Radiol. 2018 Feb;59(2):180-187. doi: 10.1177/0284185117712541. Epub 2017 Jun 8.

PMID:
28595488
19.

A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.

Faure M, Gomez E, Dorfmüller P, Mandry D, Canuet M, Kessler R, Chabot F, Chaouat A.

Respir Med Case Rep. 2017 Apr 4;21:74-77. doi: 10.1016/j.rmcr.2017.04.001. eCollection 2017.

20.

Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis.

Zuily S, Domingues V, Suty-Selton C, Eschwège V, Bertoletti L, Chaouat A, Chabot F, Regnault V, Horn EM, Erkan D, Wahl D.

Autoimmun Rev. 2017 Jun;16(6):576-586. doi: 10.1016/j.autrev.2017.04.003. Epub 2017 Apr 12. Review.

PMID:
28411166
21.

Awareness of obstructive sleep apnea-hypopnea syndrome among the general population of the Lorraine Region of France.

Arous F, Boivin JM, Chaouat A, Rumeau C, Jankowski R, Nguyen DT.

Eur Ann Otorhinolaryngol Head Neck Dis. 2017 Oct;134(5):303-308. doi: 10.1016/j.anorl.2017.02.010. Epub 2017 Mar 11.

22.

[Multicystic presentation of a lepidic mucinous adenocarcinoma].

Beurton A, Gomez E, Mandry D, Champigneulle J, Perez P, Chaouat A, Chabot F.

Rev Mal Respir. 2016 Nov;33(9):812-816. doi: 10.1016/j.rmr.2016.04.028. Epub 2016 Jul 18. French.

PMID:
27444696
23.

Initial dual oral combination therapy in pulmonary arterial hypertension.

Sitbon O, Sattler C, Bertoletti L, Savale L, Cottin V, Jaïs X, De Groote P, Chaouat A, Chabannes C, Bergot E, Bouvaist H, Dauphin C, Bourdin A, Bauer F, Montani D, Humbert M, Simonneau G.

Eur Respir J. 2016 Jun;47(6):1727-36. doi: 10.1183/13993003.02043-2015. Epub 2016 Mar 17.

24.

[Alpha-1 antitrypsin deficiency caused by Null mutation].

Perrin J, Aimone-Gastin I, Balduyck M, Mercy M, Filhine-Trésarrieu P, Odou MF, Chaouat A, Chabot F.

Rev Mal Respir. 2016 Sep;33(7):612-7. doi: 10.1016/j.rmr.2015.10.007. Epub 2015 Nov 18. French.

PMID:
26604020
25.

Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.

Calcaianu G, Canuet M, Schuller A, Enache I, Chaouat A, Kessler R.

Respiration. 2016;91(1):9-17. doi: 10.1159/000441304. Epub 2015 Oct 23.

26.

Lack of correlation between the ventilatory response to CO2 and lung function impairment in myotonic dystrophy patients: evidence for a dysregulation at central level.

Poussel M, Thil C, Kaminsky P, Mercy M, Gomez E, Chaouat A, Chabot F, Chenuel B.

Neuromuscul Disord. 2015 May;25(5):403-8. doi: 10.1016/j.nmd.2015.02.006. Epub 2015 Feb 17.

PMID:
25753091
27.

[Impact of COPD: from disability to exacerbations].

Chabot F, Zysman M, Perrin J, Mercy M, Guillaumot A, Gomez E, Kheir A, Chaouat A.

Presse Med. 2014 Dec;43(12 Pt 1):1353-8. doi: 10.1016/j.lpm.2014.08.009. Epub 2014 Oct 29. Review. French.

PMID:
25448123
28.

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy.

Montani D, Bertoletti L, Chaumais MC, Perrin S, Fabre D, Chaouat A, Jaïs X, Simonneau G, Humbert M.

Eur Respir Rev. 2014 Jun;23(132):260-3. doi: 10.1183/09059180.00005913. No abstract available.

29.

Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension.

Chaouat A, Sitbon O, Mercy M, Ponçot-Mongars R, Provencher S, Guillaumot A, Gomez E, Selton-Suty C, Malvestio P, Regent D, Paris C, Hervé P, Chabot F.

Eur Respir J. 2014 Sep;44(3):704-13. doi: 10.1183/09031936.00153613. Epub 2014 May 15.

30.

[French Pulmonary Medicine Society. Guidelines for clinical practice. Management of COPD. Update 2012: Pulmonary function tests. Full length text].

Perez T, Garcia G, Roche N, Bautin N, Chambellan A, Chaouat A, Court-Fortune I, Delclaux B, Guenard H, Jebrak G, Orvoen-Frija E, Terrioux P; French Pulmonary Medicine Society.

Rev Mal Respir. 2014 Mar;31(3):263-94. doi: 10.1016/j.rmr.2013.11.007. Epub 2014 Jan 14. Review. French. No abstract available.

PMID:
24680119
31.

[Bronchioloalveolar carcinoma: an exceptional cause of diffuse lung disease in a patient with acute myeloid leukemia].

Boubaya A, Gomez E, Guerder A, Ropion-Michaux H, Kheir A, Vignaud JM, Chaouat A, Chabot F.

Rev Mal Respir. 2014 Mar;31(3):259-62. doi: 10.1016/j.rmr.2013.07.003. Epub 2013 Aug 23. French.

PMID:
24680118
32.

[Société de pneumologie de langue française. Guidelines for clinical practice. Management of COPD. Update 2012: Pulmonary function tests (Summary)].

Perez T, Garcia G, Roche N, Bautin N, Chambellan A, Chaouat A, Court-Fortune I, Delclaux B, Guenard H, Jebrak G, Orvoen-Frija E, Terrioux P; Societe de pneumologie de langue francaise.

Rev Mal Respir. 2014 Jan;31(1):85-90. doi: 10.1016/j.rmr.2013.10.642. Epub 2014 Jan 6. French. No abstract available.

PMID:
24461450
33.

Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension.

Cracowski JL, Chabot F, Labarère J, Faure P, Degano B, Schwebel C, Chaouat A, Reynaud-Gaubert M, Cracowski C, Sitbon O, Yaici A, Simonneau G, Humbert M.

Eur Respir J. 2014 Mar;43(3):915-7. doi: 10.1183/09031936.00151313. Epub 2013 Nov 14. No abstract available.

34.

Pulmonary hypertension in chronic obstructive pulmonary disease.

Weitzenblum E, Chaouat A, Kessler R.

Pneumonol Alergol Pol. 2013;81(4):390-8. Review.

35.

Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension.

Germain M, Eyries M, Montani D, Poirier O, Girerd B, Dorfmüller P, Coulet F, Nadaud S, Maugenre S, Guignabert C, Carpentier W, Vonk-Noordegraaf A, Lévy M, Chaouat A, Lambert JC, Bertrand M, Dupuy AM, Letenneur L, Lathrop M, Amouyel P, de Ravel TJ, Delcroix M, Austin ED, Robbins IM, Hemnes AR, Loyd JE, Berman-Rosenzweig E, Barst RJ, Chung WK, Simonneau G, Trégouët DA, Humbert M, Soubrier F.

Nat Genet. 2013 May;45(5):518-21. doi: 10.1038/ng.2581. Epub 2013 Mar 17.

36.

[Combined pulmonary fibrosis and emphysema: the natural history of the disease. The chronological evolution of clinical features, respiratory function and the CT scan].

Ponçot-Mongars R, Zysman M, Regent D, Gomez E, Chaouat A, Chabot F.

Rev Mal Respir. 2013 Mar;30(3):222-6. doi: 10.1016/j.rmr.2012.06.002. Epub 2012 Jul 23. French.

PMID:
23497932
37.

Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension.

Cracowski JL, Degano B, Chabot F, Labarère J, Schwedhelm E, Monneret D, Iuliano L, Schwebel C, Chaouat A, Reynaud-Gaubert M, Faure P, Maas R, Renversez JC, Cracowski C, Sitbon O, Yaïci A, Simonneau G, Humbert M.

Chest. 2012 Oct;142(4):869-876. doi: 10.1378/chest.11-1267.

PMID:
22406961
38.

[Chronic respiratory failure].

Chaouat A, Gomez E, Chabot F.

Rev Prat. 2011 Nov;61(9):1283-90. French. No abstract available.

PMID:
22308823
39.

[Symptoms and natural history of COPD: role of the distal airways].

Chaouat A, Chabot F, Dusser D.

Rev Mal Respir. 2011 Oct;28(8):1071-8. doi: 10.1016/j.rmr.2011.08.004. Epub 2011 Oct 28. Review. French.

PMID:
22099412
40.

Beyond corticosteroids: future prospects in the management of inflammation in COPD.

Roche N, Marthan R, Berger P, Chambellan A, Chanez P, Aguilaniu B, Brillet PY, Burgel PR, Chaouat A, Devillier P, Escamilla R, Louis R, Mal H, Muir JF, Pérez T, Similowski T, Wallaert B, Aubier M.

Eur Respir Rev. 2011 Sep 1;20(121):175-82. doi: 10.1183/09059180.00004211. Review.

41.

[What are the mechanisms of breathlessness in COPD?].

Chaouat A, Gomez E, Guillaumot A, Chabot F.

Rev Prat. 2011 Jun;61(6):787. French. No abstract available.

PMID:
21826925
42.

[Disproportionate pulmonary hypertension in COPD].

Guillaumot A, Gomez E, Chaouat A, Chabot F.

Rev Prat. 2011 Jun;61(6):788. French. No abstract available.

PMID:
21826924
43.

[What are the mechanisms of obstruction in COPD?].

Gomez E, Guillaumot A, Chaouat A, Chabot F.

Rev Prat. 2011 Jun;61(6):784-5. French. No abstract available.

PMID:
21826923
44.

[Classification of COPD and prognostic factors].

Chabot F, Gomez E, Guillaumot A, Chaouat A.

Rev Prat. 2011 Jun;61(6):783. French. No abstract available.

PMID:
21826922
45.

[From COPD to chronic respiratory failure].

Chabot F, Gomez E, Guillaumot A, Chaouat A.

Rev Prat. 2011 Jun;61(6):781-6. French.

PMID:
21826921
46.

Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease.

Noureddine H, Gary-Bobo G, Alifano M, Marcos E, Saker M, Vienney N, Amsellem V, Maitre B, Chaouat A, Chouaid C, Dubois-Rande JL, Damotte D, Adnot S.

Circ Res. 2011 Aug 19;109(5):543-53. doi: 10.1161/CIRCRESAHA.111.241299. Epub 2011 Jun 30.

47.

[COPD and inflammation: Statement from a French expert group. How to treat inflammation?].

Roche N, Devillier P, Aguilaniu B, Escamilla R, Wallaert B, Burgel PR, Berger P, Brillet PY, Chambellan A, Chanez P, Chaouat A, Louis R, Mal H, Marthan R, Muir JF, Pérez T, Similowski T, Aubier M.

Rev Mal Respir. 2011 Apr;28(4):427-42. doi: 10.1016/j.rmr.2010.08.017. Epub 2011 Mar 22. Review. French.

PMID:
21549899
48.

[COPD and inflammation: statement from a French expert group. Phenotypes related to inflammation].

Perez T, Mal H, Aguilaniu B, Brillet PY, Chaouat A, Louis R, Muir JF, Similowski T, Berger P, Burgel PR, Chambellan A, Chanez P, Devillier P, Escamilla R, Marthan R, Wallaert B, Aubier M, Roche N.

Rev Mal Respir. 2011 Feb;28(2):192-215. doi: 10.1016/j.rmr.2010.08.011. Epub 2011 Feb 12. Review. French.

PMID:
21402234
49.

Update on the roles of distal airways in COPD.

Burgel PR, Bourdin A, Chanez P, Chabot F, Chaouat A, Chinet T, de Blic J, Devillier P, Deschildre A, Didier A, Garcia G, Jebrak G, Laurent F, Morel H, Perez T, Pilette C, Roche N, Tillie-Leblond I, Verbanck S, Dusser D.

Eur Respir Rev. 2011 Mar;20(119):7-22. doi: 10.1183/09059180.10010610. Review. Erratum in: Eur Respir Rev. 2011 Jun;20(120):123.

50.

[COPD and inflammation: statement from a French expert group: inflammation and remodelling mechanisms].

Aubier M, Marthan R, Berger P, Chambellan A, Chanez P, Aguilaniu B, Brillet PY, Burgel PR, Chaouat A, Devillier P, Escamilla R, Louis R, Mal H, Muir JF, Pérez T, Similowski T, Wallaert B, Roche N.

Rev Mal Respir. 2010 Dec;27(10):1254-66. doi: 10.1016/j.rmr.2010.10.004. Epub 2010 Nov 11. Review. French.

PMID:
21163401

Supplemental Content

Loading ...
Support Center